This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cardiox Corporation. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Innovations in Cardiac Output Measurement by Gamal Eddin Khalil
Introduction
Gamal Eddin Khalil is an accomplished inventor based in Redmond, WA (US). He has made significant contributions to the field of medical technology, particularly in the measurement of cardiac output. His innovative approach utilizes advanced techniques to enhance patient care and monitoring.
Latest Patents
Khalil holds a patent for a groundbreaking invention titled "Cardiac output measurement with metabolizable analyte containing fluid." This patent describes a method for measuring cardiac output using a catheter in conjunction with the indicator dilution technique. The system employs a non-thermal analyte-containing fluid that is biocompatible and metabolizable within the patient's body. An analyte concentration sensor is strategically mounted on the catheter, allowing for precise measurements of cardiac output at intervals of one to three minutes. The analyte-containing fluids used in this method include ammoniacal fluid, heparin, ethanol, a carbon dioxide releasing fluid, glucose, and anesthesia agents. The entire process is automated through a microprocessor-driven controller, which displays cardiac output and various cardiovascular parameters.
Career Highlights
Khalil's career is marked by his dedication to advancing medical technology. His work at Cardiox Corporation has positioned him as a key player in the development of innovative solutions for cardiovascular monitoring. His patent reflects his commitment to improving patient outcomes through technology.
Collaborations
Khalil has collaborated with notable professionals in the field, including Philip E Eggers and Scott Powers Huntley. These partnerships have contributed to the success of his projects and the advancement of cardiac monitoring technologies.
Conclusion
Gamal Eddin Khalil's contributions to cardiac output measurement represent a significant advancement in medical technology. His innovative patent showcases his expertise and commitment to improving patient care. Through his work, he continues to influence the field of cardiovascular monitoring positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile